Terrie Curran

Insider Reports History

Entity
Individual
Location
C/O Myovant Sciences Inc., 320 West 37 Th Street, 5 Th Floor, New York, NY
Signature
/s/ David Topper, as Attorney-in-Fact for Terrie Curran
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Terrie Curran:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Phathom Pharmaceuticals, Inc. President and Chief Executive, Director Common Stock 378K $4.43M $11.72 Jul 15, 2024 Direct
Arcutis Biotherapeutics, Inc. Director Common Stock 10.1K $110K $10.85 Nov 11, 2024 Direct
Phathom Pharmaceuticals, Inc. President and Chief Executive, Director Common Stock 3.84K $45K $11.72 Jul 15, 2024 By 401(k)
Phathom Pharmaceuticals, Inc. President and Chief Executive, Director Stock Option (Right to Buy) 475K Jan 18, 2024 Direct
Arcutis Biotherapeutics, Inc. Director Stock Option (right to buy) 27.1K Jun 14, 2024 Direct
Myovant Sciences Ltd. Director Common Shares 0 $27.00 Mar 10, 2023 Direct
Myovant Sciences Ltd. Director Stock Options (Right to Buy) 0 Mar 10, 2023 Direct

Insider Reports Filed by Terrie Curran

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ARQT Arcutis Biotherapeutics, Inc. Nov 11, 2024 1 -$94.2K 4 Nov 13, 2024 Director
PHAT Phathom Pharmaceuticals, Inc. Jul 15, 2024 1 -$397K 4 Jul 17, 2024 President and Chief Executive, Director
ARQT Arcutis Biotherapeutics, Inc. Jun 14, 2024 2 $0 4 Jun 18, 2024 Director
PHAT Phathom Pharmaceuticals, Inc. Mar 22, 2024 1 -$154K 4 Mar 26, 2024 President and Chief Executive, Director
PHAT Phathom Pharmaceuticals, Inc. Jan 18, 2024 1 $0 4 Jan 22, 2024 President and Chief Executive, Director
PHAT Phathom Pharmaceuticals, Inc. Nov 1, 2023 1 $0 4 Nov 3, 2023 President and Chief Executive, Director
PHAT Phathom Pharmaceuticals, Inc. Jul 14, 2023 3 $0 4 Jul 17, 2023 President and Chief Executive, Director
ARQT Arcutis Biotherapeutics, Inc. May 31, 2023 2 $0 4 Jun 2, 2023 Director
PHAT Phathom Pharmaceuticals, Inc. Apr 6, 2023 1 $101K 4 Apr 7, 2023 President and Chief Executive, Director
MYOV Myovant Sciences Ltd. Mar 10, 2023 8 $0 4 Mar 10, 2023 Director
PHAT Phathom Pharmaceuticals, Inc. Mar 1, 2023 1 -$12.3K 4 Mar 3, 2023 President and Chief Executive, Director
PHAT Phathom Pharmaceuticals, Inc. Jan 19, 2023 3 -$47.7K 4 Jan 20, 2023 President and Chief Executive, Director
PHAT Phathom Pharmaceuticals, Inc. Nov 21, 2022 1 -$14.6K 4 Nov 23, 2022 President and Chief Executive, Director
MYOV Myovant Sciences Ltd. Oct 26, 2022 1 $0 4 Oct 28, 2022 Director
PHAT Phathom Pharmaceuticals, Inc. Sep 1, 2022 1 $0 4 Sep 2, 2022 President and Chief Executive, Director
ARQT Arcutis Biotherapeutics, Inc. Jun 1, 2022 2 $0 4 Jun 3, 2022 Director
PHAT Phathom Pharmaceuticals, Inc. May 19, 2022 1 $0 4 May 20, 2022 President and Chief Executive, Director
PHAT Phathom Pharmaceuticals, Inc. May 13, 2022 1 $152K 4 May 16, 2022 President and Chief Executive, Director
PHAT Phathom Pharmaceuticals, Inc. Jan 19, 2022 0 $0 4/A Mar 11, 2022 President and Chief Executive, Director
MYOV Myovant Sciences Ltd. Nov 5, 2021 1 $0 4 Nov 9, 2021 Director
MYOV Myovant Sciences Ltd. Sep 9, 2021 3 -$87K 4 Sep 13, 2021 Director
MYOV Myovant Sciences Ltd. Sep 1, 2021 6 -$843K 4 Sep 3, 2021 Director
ARQT Arcutis Biotherapeutics, Inc. Jun 9, 2021 1 $0 4 Jun 11, 2021 Director